Related Experiment Video
Updated: Jun 23, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
New risk factors for atherosclerosis and patient risk assessment
Jean-Charles Fruchart1, Melchior C Nierman, Erik S G Stroes
1Departement de Recherche sur les Lipoproteines et l'Atherosclerose,Pasteur de Lille, Inserm U545 et Faculté de Pharmacie, Université du Droit et de la Santé de Lille 2, Lille, France. Jean-Charles.Fruchart@pasteur-lille.fr
Insights
Understanding traditional and novel cardiovascular risk factors improves atherosclerosis prediction. Newer factors like impaired fasting glucose and high-sensitivity C-reactive protein add to coronary disease risk assessment.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Traditional cardiovascular risk factors (lipids, hypertension) are understood for atherosclerosis initiation.
- Assessing global risk profiles requires integrating classic and novel factors for improved patient risk evaluation.
Purpose of the Study:
- To review evidence on novel cardiovascular risk factors.
- To highlight their contribution to coronary and cardiovascular disease risk.
Main Methods:
- Literature review of studies on cardiovascular risk factors.
- Synthesis of evidence on emerging risk markers.
Main Results:
- Novel factors including impaired fasting glucose, triglycerides, lipoprotein(a), homocysteine, and high-sensitivity C-reactive protein are associated with increased cardiovascular risk.
- These factors, alongside traditional ones, enhance the prediction of future cardiovascular events.
Conclusions:
- Integrating novel risk factors into global risk assessment improves cardiovascular disease prediction.
- Further research into these factors can refine preventative strategies.
Abstract:
Advances in our understanding of the ways in which the traditional cardiovascular risk factors, including standard lipid (eg, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol) and nonlipid (eg, hypertension) risk factors, interact to initiate atherosclerosis and promote the development of cardiovascular disease have enhanced our ability to assess risk in the individual patient. In addition, the ongoing identification and understanding of so-called novel risk factors may further improve our ability to predict future risk when these are included along with the classic risk factors in assessing the global risk profile. This review briefly summarizes the evidence that some newer risk factors, including impaired fasting glucose, triglycerides and triglyceride-rich lipoprotein remnants, lipoprotein(a), homocysteine, and high-sensitivity C-reactive protein, contribute to an increased risk of coronary and cardiovascular diseases.
More Related Videos
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
09:09Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management